Company · CIK 0001724344
Entasis Therapeutics Holdings Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/AEntasis Therapeutics Holdings Inc.0001140361-22-025754 · 60.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001140361-22-025725 · 280.6 KBSEC(opens sec.gov)
- SC 13D/AEntasis Therapeutics Holdings Inc.0001140361-22-020324 · 104.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001140361-22-020249 · 854.3 KBSEC(opens sec.gov)
- 10-K/AEntasis Therapeutics Holdings Inc.0001558370-22-006630 · 763.4 KBSEC(opens sec.gov)
- 10-QQuarterly update0001558370-22-006098 · 5.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001558370-22-006042 · 252.7 KBSEC(opens sec.gov)
- SC 13D/AEntasis Therapeutics Holdings Inc.0001104659-22-033706 · 50.0 KBSEC(opens sec.gov)
- 10-KAnnual report0001558370-22-002788 · 8.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001558370-22-002723 · 260.8 KBSEC(opens sec.gov)
Insiders
- Altarac DavidChief Medical Officer
- ASTRAZENECA AB10% Owner
- ASTRAZENECA PLC10% Owner
- Berger Heather A.Director
- Blackstone Group Management L.L.C.10% Owner
- Blackstone Holdings I/II GP L.L.C.10% Owner
- Blackstone Holdings II L.P.10% Owner
- Blackstone Inc.10% Owner
- BONDERMAN DAVID10% Owner, Former 10% Owner
- Clarus Lifesciences III, L.P.10% Owner
Tickers
No tickers on record.
Addresses
business
35 GATEHOUSE DRIVE
WALTHAM, MA, 02451
mailing
35 GATEHOUSE DRIVE
WALTHAM, MA, 02451
Former names
- Entasis Therapeutics Ltd2018-08-17
Same industry